This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Beyond the Abstracts
Urologic Oncology
Renal Cancer
Beyond the Abstracts
A European multi-institutional study of the prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib, "Beyond the Abstract," by Aristotle Bamias
November 13, 2014
Exonic methylation of VHL in renal cell carcinoma, "Beyond the Abstract," by Fei Lian and John A. Petros
November 11, 2014
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments, "Beyond the Abstract," by William Leenders, PhD, et al
November 11, 2014
Ampullary tumor caused by metastatic renal cell carcinoma, "Beyond the Abstract," by Jiaobo Zhai, MD
October 24, 2014
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma, "Beyond the Abstract," by Sandy Giuliano, Mélanie Guyot, Renaud Grepin, and Gilles Pages
October 10, 2014
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment, "Beyond the Abstract," by Renpei Kato, MD
August 26, 2014
Two successful cases of the treatment of transitional cell carcinoma involving the renal pelvis in either a functional or anatomical solitary kidney, "Beyond the Abstract," by Bo Yang
August 7, 2014
Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: Role of the mTORC1/2 and hypoxia-inducible factor pathways, "Beyond the Abstract," by Veronica A. Carroll, PhD
July 25, 2014
Adequate immunosuppression and oncological control employing temsirolimus as a base immunosuppressant for a recipient with metastatic renal cancer, "Beyond the Abstract," by Shih-Chieh Jeff Chueh, MD, PhD
July 24, 2014
A 10-year, single institution review of renal cell carcinoma with venous neoplastic thrombosis, "Beyond the Abstract," by Giacomo Maria Pirola, MD
July 22, 2014
The influence of different tumor enhancement measurement approaches on pretreatment differentiation, by CT, of renal cell carcinoma subtypes, "Beyond the Abstract," by Ivan Žokalj
July 12, 2014
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma, "Beyond the Abstract," by Denis L. Fontes Jardim and David S. Hong
June 26, 2014
Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma, "Beyond the Abstract," by Ron Rodriguez, MD, PhD with Christos Georgiades, MD, PhD
June 24, 2014
The association between statin medication and progression after surgery for localized renal cell carcinoma, "Beyond the Abstract," by Robert J. Hamilton, MD, MPH, FRCSC
June 23, 2014
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis, "Beyond the Abstract," by Adam Shrewsberry, MD
June 20, 2014
A review of the current role of targeted therapy in the treatment of metastatic renal carcinoma, "Beyond the Abstract," by Paulo Jaworski, MD
June 17, 2014
Washington University long-term experience with renal cryoablation versus robot-assisted partial nephrectomy, "Beyond the Abstract," by Eric H. Kim, MD
June 11, 2014
Renal cancer-selective englerin A induces multiple mechanisms of cell death and autophagy, "Beyond the Abstract," by Ayse Batova, PhD
June 6, 2014
A Malaysian single centre perspective of clinical prognostic factors and survival outcome in renal cell carcinoma patients, "Beyond the Abstract," by Ning Yi Yap
May 16, 2014
Management of renal cell carcinoma with level I tumor thrombi using a combined retroperitoneoscopic and transperitoneal laparoscopic technique, "Beyond the Abstract," by Oner Sanli and Abubekir Boguk
May 14, 2014
Page 9 of 13
Start
Prev
4
5
6
7
8
9
10
11
12
13
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free